Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Group Testing for SARS-CoV-2: Forward to the Past?

Pouwels KB. et al, (2020), Pharmacoecon Open

Group Testing for SARS-CoV-2: Forward to the Past?

Pouwels KB. et al, (2020), PharmacoEconomics - Open

Registered Reports: Time to Radically Rethink Peer Review in Health Economics

CLARKE P. et al, (2020), PharmacoEconomics - Open

Defining and measuring health poverty

Clarke P. and Erreygers G., (2020), Social Science and Medicine, 244

Transparency in Decision Modelling: What, Why, Who and How?

Sampson CJ. et al, (2019), Pharmacoeconomics

The impact of Medicare part D on income-related inequality in pharmaceutical expenditure

Carvalho N. et al, (2019), International Journal for Equity in Health, 18

Load More

Handbooks in Health Economic Evaluation

A series published by Oxford University Press.

Find out more